(Q33564034)

English

A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases

scientific article published on November 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

multicenter clinical trial

0 references

connective tissue

1 reference

based on heuristic

inferred from title

1 reference

10.1136/ARD.50.11.800

https://api.crossref.org/works/10.1136/ARD.50.11.800

8 November 2022

1 reference

10.1136/ARD.50.11.800

https://api.crossref.org/works/10.1136/ARD.50.11.800

8 November 2022

author name string

H. I. Torley

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722967

8 November 2022

R. Madhok

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722967

8 November 2022

H. A. Capell

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722967

8 November 2022

R. M. Brouwer

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722967

8 November 2022

P. J. Maddison

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722967

8 November 2022

C. M. Black

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722967

8 November 2022

H. Englert

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722967

8 November 2022

J. A. Dormandy

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722967

8 November 2022

H. R. Watson

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722967

8 November 2022

language of work or name

0 references

publication date

1 November 1991

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

full work available at URL

https://europepmc.org/articles/PMC1004562

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722967

8 November 2022

https://europepmc.org/articles/PMC1004562?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722967

8 November 2022

https://syndication.highwire.org/content/doi/10.1136/ard.50.11.800

1 reference

10.1136/ARD.50.11.800

https://api.crossref.org/works/10.1136/ARD.50.11.800

8 November 2022

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

800-804

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004562

21 June 2018

Treatment of raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004562

21 June 2018

Uses and abuses of analysis of variance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004562

21 June 2018

Prostaglandin E1 vasospastic disease and thermography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004562

21 June 2018

Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynauds syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004562

21 June 2018

Double-blind trial of CL115,347, a transdermally absorbed prostaglandin E2 analogue, in treatment of Raynaud's phenomenon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004562

21 June 2018

Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004562

21 June 2018

Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004562

21 June 2018

Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004562

21 June 2018

Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004562

21 June 2018

Treatment of Raynaud's phenomenon by fibrinolytic enhancement.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004562

21 June 2018

Nifedipine and Raynaud's phenomenon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004562

31 October 2018

Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function

1 reference

https://pubmed.ncbi.nlm.nih.gov/1722967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of nifedipine in the treatment of Raynaud's phenomenon

1 reference

https://pubmed.ncbi.nlm.nih.gov/1722967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

INTERMITTENT EPOPROSTENOL (PROSTACYCLIN) INFUSION IN PATIENTS WITH RAYNAUD'S SYNDROME

1 reference

https://pubmed.ncbi.nlm.nih.gov/1722967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of polymorphonuclear leukocyte adherence by prostacyclin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1722967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1722967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)

1 reference

https://pubmed.ncbi.nlm.nih.gov/1722967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of Raynaud's Syndrome with prostacyclin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1722967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defective fibrinolytic response in atherosclerotic patients--effect of iloprost and its possible mechanism of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/1722967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1722967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal biochemical and cellular parameters in the blood of patients with Raynauds phenomenon

1 reference

https://pubmed.ncbi.nlm.nih.gov/1722967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

13

1 reference

10.1136/ARD.50.11.800

https://api.crossref.org/works/10.1136/ARD.50.11.800

8 November 2022

Identifiers

10.1136/ARD.50.11.800

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33564034&oldid=1767577147"